tradingkey.logo
搜尋

Elanco Animal Health Inc

ELAN
添加自選
24.086USD
+0.126+0.53%
交易中 美東報價延遲15分鐘
11.97B總市值
虧損本益比TTM

關於 Elanco Animal Health Inc 公司

Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.

Elanco Animal Health Inc簡介

公司代碼ELAN
公司名稱Elanco Animal Health Inc
上市日期Sep 20, 2018
CEOSimmons (Jeffrey N)
員工數量9000
證券類型Ordinary Share
年結日Sep 20
公司地址450 Elanco Circle
城市INDIANAPOLIS
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編46221
電話18773526261
網址https://www.elanco.com/
公司代碼ELAN
上市日期Sep 20, 2018
CEOSimmons (Jeffrey N)

Elanco Animal Health Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
101.69K
+16.59%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
94.39K
+4.96%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
83.83K
+35.69%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
71.18K
+12.12%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%

常見問題

Elanco Animal Health Inc的前五大股東是誰?

Elanco Animal Health Inc的前五大股東如下:Mr. Jeffrey N. (Jeff) Simmons

有多少機構持有Elanco Animal Health Inc(ELAN)的股份?

截至2026Q1,共有950家機構持有Elanco Animal Health Inc的股份,合計持有的股份價值約為549.30M,占公司總股份的109.98% 。與2025Q4相比,機構持股有所增加,增幅為-60070109.00。

哪個業務部門對Elanco Animal Health Inc的收入貢獻最大?

在2026Q1,Farm Animal業務部門對Elanco Animal Health Inc的收入貢獻最大,創收2.36B,占總收入的50.10% 。
KeyAI